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ABSTRACT
Articular cartilage is essential part of the human body that aids in support and
locomotion. It has unique biochemical and biomechanical properties that allow it to act
as a shock absorber to disperse and distribute loading of the joints. However, it has a
limited capacity to repair itself because it is not vascularized and must receive its
nutrients from the surrounding synovial fluid. Articular cartilage damage can lead to
many pathological conditions, including osteoarthritis.

Currently, there are many

surgical treatment methods that repair some of the damage if it is localized, but for
widespread degradation seen in osteoarthritis, there are no effective means of reparative
treatments. Research has been ongoing to find a cure for this degeneration, and recently
there has been focus on the potential of using nanoparticles as a drug delivery method in
treating articular cartilage damage.

Nanoparticles could be used to deliver growth

factors, drugs, or genes to attempt to restore the tissue to its native state. However, the
permeation of nanoparticles due to physiological loading of articular cartilage must first
be characterized.
To conduct experiments on articular cartilage, a means of providing physiological
compressive loading had to be established. After consulting the literature, a customdesigned dynamic compression loading apparatus was constructed. It was controlled
using an electro-mechanical linear actuator, specifically an eccentric cam, to provide
various loading conditions of frequency and strain. It was determined that the device
could consistently and accurately provide axial loading in the physiological range for
articular cartilage applications.
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To characterize the permeation of nanoparticles in articular cartilage, experiments
were carried out with cartilage exposed to gold nanoparticles under various loading
conditions using the custom designed compression device. The tissue was then observed
with electron microscopy to observe the presence of gold nanoparticles. The images
taken qualitatively indicated the extent of gold nanoparticle permeation on the surface
and inside the cartilage. It was seen that the gold nanoparticles were only observed in the
dynamically compressed tissue in varying amounts. The cartilage tissue under higher
frequency axial loading in the physiological range showed a greater amount of
nanoparticle permeation. However, more work needs to be done to understand the zones
of the articular cartilage that are affected by the convective transport and permeation of
the gold nanoparticles.
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CHAPTER 1: GOLD NANOPARTICLE DRUG DELIVERY
FOR ARTICULAR CARTILAGE REPAIR
1.1 Market Analysis of Articular Cartilage Damage in the US
There is a large market for articular cartilage repair, specifically with regard to
osteoarthritic damage.

Osteoarthritis is one of the most common form of chronic

disability, and in the US, it accounts for 3.4-13.2 billion USD per year in work-related
limitations costs1.

Healthcare treatments in 2004 amounted to over 11 million

physician/outpatient visits, 632,000 joint replacements, and 662,000 hospitalizations,
bringing the total healthcare cost to 22.6 billion USD2. Unfortunately with an aging
population and increased prevalence of obesity, the disease is increasing in the number of
cases and, subsequently, the total cost.
1.2 Current Treatments to Repair Articular Cartilage
Due to the avascular nature of articular cartilage, there is an extremely limited
capacity for self-renewal, and thus, the patient must decide whether to live with the
cartilage damage and associated complications or seek out clinical intervention.
Currently, there are several surgical methods that repair localized articular cartilage
damage and slow further deterioration. However, when there is widespread damage as
seen in osteoarthritis, there are no effective means of repairing the tissue, and often times
a joint replacement surgery is recommended.

1

1.3 Gold Nanoparticles for Drug Delivery
In the case of avascular articular cartilage, traditional treatment methods of
administering drugs through the circulatory system cannot be used and the treatment must
be done locally. Gold nanoparticles have optimal properties that make it an ideal smart
drug delivery system for the administration of drugs, growth factors, or genes for
cartilage repair.
1.4 Overview of Study and Chapters
The following studies aim to determine the effects of physiological loading of
articular cartilage on the permeation of gold nanoparticles. The purpose is to determine
the effectiveness of these nanoparticles as a means of drug delivery through convective
transport.

Chapter 2 provides an overview of cartilage anatomy and physiology,

specifically with regard to articular cartilage. In Chapter 3, an introduction to gold
nanoparticles is given as well as a look into their potential use in drug delivery to repair
articular cartilage damage.

The design and construction of a custom dynamic

compression loading apparatus is described in Chapter 4. In Chapter 5, the experiments
that were conducted to determine gold nanoparticle permeation are detailed as well as the
subsequent results that were obtained. Finally, Chapter 6 summarizes the findings of the
studies as well as the potential for future work.

2

1.5 References
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CHAPTER 2: ARTICULAR CARTILAGE ANATOMY AND PHYSIOLOGY

In order to determine if gold nanoparticles as a drug delivery system would be an
effective means of treating cartilage damage, it is necessary to understand the articular
cartilage anatomy and physiology. The following chapter gives an overview of cartilage
anatomy and physiology as well as common pathologies affecting the normal function of
this tissue. The chapter also discusses the need for more effective solution to repair
damaged cartilage that is not as invasive as the current range of treatment options.

2.1 Cartilage Anatomy and Physiology
The musculoskeletal system functions to support the structure of the body and
give humans the ability of locomotion. It consists of bones, which make up a skeleton of
hard tissue, and soft tissues such as the muscles, ligaments, tendons, and cartilage, which
connect the skeleton together at joints. Cartilage is an essential component of the human
anatomy, and it serves many physiological roles in the musculoskeletal system. The
primary functions are to support surrounding soft tissue, to provide an articulating surface
between bones, and to serve as a framework for bone formation. Structurally, cartilage is
a supporting connective tissue that is both flexible and resilient. The extracellular matrix
makes up more than 95% of the cartilage volume3 and is composed of collagen and
elastin fibers embedded in an extensive ground substance that is rich in proteinpolysaccharide complexes known as proteoglycans. The cells that make up the other less
than 5% of cartilage tissue are called chondrocytes, and they occupy compartments in the
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extracellular matrix called lacunae. These cells serve to produce and maintain the ground
substance. There are three types of anatomically and physiologically different cartilage:
hyaline cartilage, elastic cartilage, and fibrocartilage.

Figure 2.1: Cartilage Distribution in the Body11

They are characterized by the composition of the extracellular matrix found and
the function in the body, as seen in Figure 2.1. Hyaline cartilage contains fine collagen
fibers, elastic cartilage contains densely-packed elastic fibers, and fibrocartilage contains
large collagen fibers4. For the purposes of this study, we will focus solely on hyaline
cartilage found in the joints.
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Hyaline cartilage is the most common type of cartilage and its name comes from
the Greek word hyalos meaning glassy due to its glassy, white appearance. It can be
found on the ends of long bones in articulating joints, in which case it can also be referred
to as articular cartilage. Articular cartilage has a low friction coefficient, thus providing a
surface that allows for smooth movement. The components in its biochemical structure,
discussed below, give it the ability to effectively disperse and distribute the loading
experienced in the joint, acting as a shock absorber. The thickness of the articular
cartilage varies from joint to joint5, but is approximately 2-4 mm in the human hip and
knee6. The classification of hyaline cartilage is determined by its function in the body
and the molecular composition of its extracellular matrix.

The relative molecular

composition of the cartilage itself and the extracellular matrix is shown in Figure 2.2.

Figure 2.2: Biochemical Composition of Hyaline Cartilage3
The collagen fibers that are present in the extracellular matrix serve as a meshwork to
resist tensile forces experienced upon the joint. Collagen is a protein that is produced by
chondrocytes, and in adult articular cartilage type II is the most predominant at around
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80% of total collagen content3, although types III, VI, IX, X, XI, XII, and XIV are also
present. Collagen is structured as a triple helix of chains that are composed of a repeating
amino acid sequence of glycines, prolines, and hydroxyprolines. It is found throughout
articular cartilage as collagenous fibrils arranged in various orientations to resist tensile
forces in the joint.
The proteoglycans that make up the next highest percentage of the extracellular
matrix function to resist compressive forces experienced upon the joint.

They are

comprised of a protein core to which polysaccharide chains are attached. These chains
are also known as glycosaminoglycans or GAGs, and hyaline cartilage contains three
kinds: hyaluronan, chondroitin sulfate, and keratin sulfate. Aggregran molecules are the
most prevalent proteoglycan in adult articular cartilage. These molecules consist of
chondroitin sulfate and keratin sulfate attached to a protein core. Additionally, the
aggrecan structures will bind to a single chain of hyaluronan via the presence and
stabilization of a link protein to form a proteoglycan aggregate7, as seen below in Figure
2.3.

Figure 2.3: Structure of a Proteoglycan Aggregate
Image from Wikimedia Commons54
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These large macromolecules are immobilized within the collagen network of the cartilage
ground substance, and it is here that they absorb water. This swelling that occurs is due
to the net negative charge or hydrophilicity of the sulfate groups on the GAG chains to
create a “fixed charge density”8. This accounts for the 60-80% water content found in
articular cartilage3, and it is the reason that cartilage is so effective at dispersing and
distributing compressive loads in the joint.

The compression of cartilage leads to

pressurization of the fluid, which supports the majority of the initial compressive load
and acts to make the cartilage last longer with age.

However, the decrease in

proteoglycan size due to aging9,10 can cause a decreased fluid pressurization, causing the
cartilage itself to experience higher mechanical loading. Over time this improper loading
can lead to deterioration of the articular cartilage and is seen in diseases, such as
osteoarthritis, which will be discussed in subsequent sections.
The articular cartilage is divided into four basic zones, seen below in Figure 2.4,
and they are organized based on their location and morphology.
S

IZ

D

C

Figure 2.4: Classification of Zones in Normal Articular Cartilage
SZ: Superficial Zone, IZ: Intermediate Zone, DZ: Deep Zone,
CZ: Calcified Zone (H&E, 40x Total Magnification)
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The first zone is known as the superficial or tangential zone, which makes up about 1020% of the cartilage thickness. It is located on the surface of the articular cartilage and
composed of fine, densely-packed collagenous fibers and flattened chondrocytes arranged
tangentially to the loaded surface. The second zone is the intermediate zone, which is
also known as the middle zone or transitional zone, and it accounts for 40-60% of the
cartilage thickness. This layer consists of randomly oriented collagen fibers of large
diameter and spherically shaped chondrocytes. The deep zone makes up 20-50% of the
cartilage thickness, and it is the last layer with solely hyaline cartilage with no bone
tissue. The collagen fibers are arranged perpendicular to the weight bearing surface, and
the chondrocytes are grouped together in columns. The final layer is known as the
calcified zone, which is where the region of cartilage tissue is becoming ossified and is
transitioning to bone tissue.

Underneath this layer is the subchondral bone, which

attaches to the cartilage to serve as an anchorage point. The individual layers can be
more closely examined in Figure 2.5 below.

SZ

IZ

DZ

Figure 2.5: Zones of Normal Articular Cartilage
SZ: Superficial Zone, IZ: Intermediate Zone, DZ: Deep
Zone (H&E, 40x Total Magnification)
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2.2 Articular Cartilage Damage and Repair Mechanisms
As noted in the previous section, articular cartilage is a resilient tissue that is able
to withstand the constant stresses placed on the joints throughout a human lifespan.
However, when there is damage to the cartilage, there is an extremely limited healing
response. The reason for the limited repair capabilities of cartilage lies in its unique
anatomical and physiological properties.

In order to maintain its biomechanical

properties, the chondrocytes in articular cartilage produce a chemical that prevents the
vasculature from occupying any part of the extracellular matrix11. This means that the
tissue is avascular, and the cells contained in the tissue must exchange nutrients or waste
with the synovial fluid. The exchange of these substances occurs by diffusion across the
cartilage surface and is mediated by physiological motion in the joint. For this purpose,
the articular cartilage exhibits permeability properties that favor small molecule
diffusion. It has been shown that small molecules have diffusion coefficients in cartilage
of approximately 40% in aqueous solutions, whereas larger molecules are much more
restricted12. Other reasons for the lack of a healing response to injury include the slow
movement of lacunae-bound chondrocytes and the limited proliferation capabilities of
mature chondrocytes.
In order to analyze articular cartilage damage, a classification system was
developed to have a uniform system of measuring the extent of the damage, as shown in
Table 2.1. Partial-thickness defects, seen in grade II and III injuries, are those in which
the damage does not penetrate into the subchondral bone. They can be characterized by
decreased proteoglycan content and increased hydration, which correlates to decreased
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cartilage stiffness, increased hydraulic permeability, and eventually increased
extracellular matrix damage13.

These partial-thickness injuries exhibit little to no

spontaneous healing and can lead to further deterioration of the articular cartilage. Fullthickness defects, seen in grade IV injuries, are those in which the damage penetrates into
the subchondral bone. These injuries exhibit an alternative repair mechanism as blood
from the underlying vasculature promotes scar tissue formation. However, the scar tissue
that forms is composed of fibrocartilage, which is denser than and not as flexible as
hyaline cartilage13. It is this inability to effectively heal damaged regions of the cartilage
that lead to the various pathologies discussed in the next section.
Table 2.1: Classification of Structural Damage to Articular Cartilage14
Grade 0

Normal cartilage

Grade I

Softening and swelling of cartilage

Grade II

Presence of a partial-thickness defect that
consists of fragmentation and fissures that
do not reach the underlying bone or are less
than 1.5 cm in diameter
Presence of a partial-thickness defect that
consists of fragmentation and fissures that
reach the underlying bone in an area
greater than 1.5 cm in diameter
Presence of a full-thickness defect that
exposes subchondral bone

Grade III

Grade IV

2.3 Pathologies
There are several pathologies that can result in articular cartilage degradation, but
the primary mechanisms of damage are traumatic injury and osteoarthritis. Traumatic
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injuries are those in which the articular cartilage in a joint experiences a high energy
impact or repeated loading of non-ideal conditions over a long period of time. Injurious
impact loading has been defined as a very small time to peak load and also having one of
the following characteristics: a stress rate of greater than 1000
than 500 , or a loading rate greater than 100
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, a strain rate of greater

. However, cartilage injury can still

occur if repeated compression of smaller, yet still non-ideal, loads and frequencies take
place over a long period of time. This compressive loading over time is the basis of the
other primary mechanism of cartilage damage, known as osteoarthritis.
Osteoarthritis, also known as degenerative joint disease, is a form of articular
cartilage damage referred to as the normal “wear and tear” on a joint. The underlying
cause is unknown, but osteoarthritis is known to be associated with loading of the joint
over time that is due to aging. It can affect any joint in the body, but it is primarily found
in the load bearing joints of the hips and knees as well as the joints of the hands, feet, and
spine. The symptoms of the disease are pain, stiffness, swelling, and even loss of motion
in a joint. It is the most common joint disorder— more than half of the US adult
population develops osteoarthritis16.

With an aging population, increased life

expectancy, and the increase in obesity, osteoarthritis is expected to become more
prevalent than the 27 million adult Americans already living with the disease in 200517.
At present, there are no cures for osteoarthritis, and the disease gradually gets worse over
time. The staggering statistics and current lack of a cure bring light to a grave situation
for which a better solution should be researched exhaustively.
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2.4 Current Treatments
There are no extremely effective ways to diagnose cartilage injury noninvasively,
but MRI have proven to be a valuable tool in providing anatomic details of the extent of
cartilage injury through noninvasive means18. The current “gold-standard” in detecting
cartilage damage is through minimally invasive means of arthroscopy, in which the
surgeon will make a small incision to insert an endoscope for observation. Once the
damage has been assessed, the consulting physician and patient can pursue a course of
action. Currently there is no cure for cartilage damage, but there are a number of ways
that the effects of articular cartilage damage can treated through non-surgical and surgical
methods. In order to manage the damage non-operatively, the patient can take nonsteroidal anti-inflammatory drugs (NSAIDS) to reduce pain, exercise daily to improve
joint movement, lose weight to reduce loading on the joint, or seek physical therapy to
rehabilitate the injury. There are several surgical techniques that have been developed by
surgeons and researchers to attempt to slow the progression of deterioration by repairing
damage and joint function. They can be grouped into four main categories: arthroscopic
lavage/debridement, marrow-stimulation, osteochondral grafts, and cell-based repair.
The first surgical technique is known as the arthroscopic repair procedure of
lavage and debridement, and it is a simple method that is moderately useful for shortterm treatment. Lavage is the washing out of the joint to clear away any debris, and
though its mechanism is unclear, it has been shown to relieve joint pain19. Debridement
is the removal of any damaged tissue, especially loose flaps that may be causing
impingement of the joint. The category of arthroscopic repair is a bit of misnomer, as the
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techniques used only clean up the affected area and do not repair the tissue. Thus, this
method is not usually recommended due to the beneficial results diminishing after only a
few short years.
Another procedure that is performed with arthroscopy is the marrow-stimulating
technique of microfracture surgery.

It involves the creation of small holes or

microfractures that penetrate into the subchondral bone to allow the blood supply to
repair the tissue. The blood contains primitive stem cells and forms a fibrin clot, which
then remodels to fibrocartilage. As discussed above, the fibrocartilage does not possess
the same mechanical properties of hyaline cartilage, and thus the articular cartilage is not
fully repair and may experience further degradation. This method is generally performed
on patients younger than 40, typically athletes or those having traumatic impact injuries,
with localized small amounts of cartilage damage.
Osteochondral autografts and allografts may be also be used to attempt to repair
the articular cartilage damage in a joint.

This procedure is typically known as

osteoarticular transfer system (OATS) or mosaicplasty.

It involves the moving of

cartilage from undamaged, non-load bearing parts of the joint to the affected area. Small
plugs of tissue are excised and then implanted into holes that have been drilled out of the
damaged region. Unfortunately, the region that the cartilage was taken from can suffer
donor site morbidity. This method is generally performed on patients younger than 50,
typically athletes or those having traumatic impact injuries, with localized small amounts
of cartilage damage.
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The procedure of autologous chondrocyte implantation (ACI) is a cell-based
repair treatment that is more advanced than the other procedures and has becoming more
widespread. It involves the harvesting of the patient’s own chondrocytes, which are then
cultured over four to six weeks and then reimplanted into the damaged region of the
cartilage to repair the defect. In this manner, hyaline cartilage is the tissue that fills in the
affected area, not fibrocartilage.

One of the problems with this procedure is the

unintended necessity of follow-up arthroscopic surgeries.

This method is generally

performed on patients younger than 60, typically athletes or those having traumatic
impact injuries, with localized small amounts of cartilage damage.
These treatment methods are primarily used to repair small areas of cartilage
damage, but in the case of widespread articular cartilage damage seen in severe
osteoarthritis, treatment options are extremely limited. If none of the above non-surgical
or surgical treatments are appropriate or effective in treating severe osteoarthritis, then
joint replacement surgery may be the best option.

Joint replacement surgery or

arthroplasty, involves the removal of the damaged articular surface and replacing it with
prosthesis. It is the most common form of relieving joint pain and restoring motion in the
treatment of severe osteoarthritis. However, these methods of treatment show moderate
results at best, and thus there is a pressing need for a more effective means of treatment in
articular cartilage damage. The potential for using gold nanoparticles as an alternative
means of cartilage repair is currently under investigation and will be discussed in the next
chapter.
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CHAPTER 3: CLINICAL SIGNIFICANCE OF GOLD NANOPARTICLES

In order to understand the possible use of gold nanoparticles as a drug delivery
system for the treatment of articular cartilage damage, it is necessary to characterize their
properties. The following chapter gives an overview of gold nanoparticles as well as
common biological applications in fields of imaging and targeted drug delivery. The
application of gold nanotechnology in the field of cartilage tissue engineering and repair
will also be discussed.

3.1 Introduction to Gold Nanoparticles
Gold nanoparticles, or AuNPs, have been known since ancient times, but it is not
until relatively recently that they have undergone more rigorous investigation. As far as
biomedical applications, colloidal gold has only been in use since 197120. They are submicrometer sized particles that are suspended in a fluid and exhibit unique optical,
electronic, and magnetic properties that can be altered during their synthesis, based on the
manufactured size and shape of the particles21.

Gold nanoparticles are also

biocompatible, ideal dimensions, and are easily characterized. Their biocompatibility in
the body, paradoxically in addition to their high chemical reactivity, is of great interest
for biomedical applications22.

The nanoparticles have a solid core that gives them

stability and a monolayer that is able to undergo thiol surface modification for specific
biological application. The dimensions exhibited by gold nanoparticles are also on the
same scale as the cellular species of interest. Gold nanoparticles can be easily observed
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under electron microscope due to their high electron density and specific manufactured
shape, as seen in Figure 3.1. It is these unique properties that have garnered attention for
gold nanoparticles for use in biosensors, diagnostic assays, imaging, and targeted drug
delivery. For the purposes of this study, the latter two applications will be discussed
further in the next section.

Figure 3.1: SEM Image of Spherical
Gold Nanoparticles of 20 nm
3.2 Gold Nanoparticles for Use in Imaging
As discussed previously, gold nanoparticles have a high electron density that
makes them easily visible using electron microscopy as well as X-ray analysis23. This
can aid in the detection of diseases, as the nanoparticles can first be conjugated with
antibodies and then imaged for diagnosis24. Nanoparticles can also be loaded with
various contrast agents like gadolinium to increase sensitivity in imaging modalities such
as magnetic resonance imaging and computed tomography, just to name a few. And due
to the small size of the gold nanoparticles, they are not removed from the body quickly
and allows for longer imaging time25. Gold nanoparticles also exhibit the property of
localized surface plasmon resonance (LSPR), which is described as collective oscillation
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of conductive electron under light excitation. This property allows gold nanoparticles to
also be observed using dark field microscopy of biological samples26.

3.3 Gold Nanoparticles for Use in Targeted Drug Delivery
Drugs can have many routes of administration depending on the application, and
ultimately the drug should reach its intended target either on its own or with the help of
cellular transport. However, orally and intravenously administered drugs may not reach
their target or could target other parts of the body that can lead to unintended negative
side effects. This has led to the development of smart drug delivery which specifically
targets the diseased tissue and is more effective than traditional means of drug delivery.
The approximate equation for the time it takes for solute species to diffuse into a tissue
can be given as

where x is the mean distance traveled and D is the diffusion

coefficient of the solute of interest. It can be seen that diffusion time increases with the
square of the distance to be traveled, and thus in the case of articular cartilage of 2-4 mm,
gold nanoparticles would take far too long to permeate the tissue by passive diffusion.
For this purpose, gold nanoparticles could be used to deliver drugs more precisely and
rapidly at in articular cartilage applications due to the convective transport that
physiological motion causes in the joint.
As discussed previously, gold nanoparticles can be conjugated with antibodies,
proteins, growth factors, or other targeting moieties via surface modification. This allows
for the gold nanoparticles to selectively target the cells or subcellular components of
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interest. The surface modification is achieved by adsorption of the ligand to the surface
of the nanoparticle27. For example in the treatment of cancer, gold nanoparticles can be
conjugated with antibodies with specificity for epithelial growth factor28, which is a
defining characteristic of cancerous tumors. Additionally, once the gold nanoparticles
have reached the intended target, infrared light can be used to melt the particles to release
the drug payload in a controlled and sustained manner29. This occurs due to gold’s
unique property of converting absorbed light into heat via localized photoactivation.
In the field of cartilage tissue engineering, there is not a large body of research on
the topic of gold nanoparticles for use in treating articular cartilage damage. However,
Park and his colleagues have shown that nanoparticles could be loaded with transforming
growth factor β1 (TGF- β1) to slowly release the growth factor to chondrocytes resulting
in increased levels of collagen and aggrecan30. The nanoparticle constructs were also
implanted into nude mice and induced chondrocytes to produce an abundant amount
extracellular matrix rich in proteoglycans30.

Thus, the nanoparticles could be

successfully used to deliver growth factors to diseased articular cartilage to attempt to
repair the damage. This has far-reaching implications as gold nanoparticles could be an
effective means of delivering drugs, growth factors, or genes to defects in the articular
cartilage31, but further investigation must be performed to determine the biological
mechanisms of gold nanoparticle permeation into the tissue.
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CHAPTER 4: DESIGN OF A LOW-COST CUSTOMIZABLE DYNAMIC
COMPRESSION APPARATUS

In order to characterize the biomechanics of articular cartilage and the potential
for using gold nanoparticles to permeate into the tissue, the physiological environment of
the tissue must be mimicked.

The following chapter gives an overview of the

requirements necessary in designing a cartilage bioreactor to replicate the loading found
in the joints as well as the various devices found most commonly in the literature. The
chapter discusses the apparatus that was constructed and its effectiveness in articular
cartilage applications.

4.1 Background
The biochemical composition of articular cartilage in joints and resulting
biomechanical fluid pressurization in response to loading give it unique properties that
allow it to disperse mechanical loads effectively. Thus, it is apparent that mechanical
loading must play a major role in the normal functionality and health of cartilage.
Specifically, the proteoglycan content of cartilage provides the tissue with the innate
ability to resist the everyday compressive forces experienced in the joints. It has been
shown that static compression of articular cartilage results in a decrease in proteoglycan
content, while dynamic compression of the cartilage increases proteoglycan content32,33.
Additionally, solutes diffuse into the articular cartilage from the surrounding synovial
fluid by passive diffusion as well as convective transport induced by dynamic
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compression loading of the joint34. Thus in an attempt to characterize the permeation of
any substance into the tissue, the physiological conditions of the joint must be replicated
in a bioreactor with a tightly controlled environment35.
A bioreactor is an engineered device that functions to mimic the body’s own
biological, chemical, and mechanical conditions for the tissue or cells that are to be
housed within the chamber. Under optimum conditions, the tissue or cells will have the
same structure, properties, and integration that can be observed in vivo35.

For the

purposes of this study, a bioreactor specifically for articular cartilage must be constructed
and manufactured to control both physiological mechanical and biological stimuli for
tissue explants. There are several general requirements to keep in mind when designing a
bioreactor device, and they are as follows: simplicity, material selection, and sensor
incorporation35.
Simplicity should be a defining characteristic in the final design of the
manufactured device, so as to make it as smooth as possible in running the necessary
experiments. The simplicity is important both in making the bioreactor effective in
reducing exposure of the tissue to non-ideal conditions as well as in ease of use for the
operator. There should be as few moving parts and machined recesses as possible to
avoid any possible sources of contamination to the chamber environment. The device
must also a short disassembly and reassembly time to ensure efficiency and reduction in
the time outside of the incubator for the tissue or cells. In addition to making the device
more effective in maintaining optimal conditions, the device should incorporate elements
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that make it more user-friendly and allow it to be easily controlled. The device should
also be as inexpensive as possible to make it more attainable.
Careful consideration should be given to the materials selection of the device to
guarantee that the bioreactor can support the proper growth and function of the tissue or
cells. The materials that are to come in contact with any biological fluids or tissues must
be bioinert to ensure that that it does not elicit an adverse response. The device must be
durable in withstanding the hot, humid (37°C, 95% relative humidity) environment of the
incubator. The materials in the device should also be easily sterilized with an autoclave
to allow for quick processing and reuse. Thus for the construction of the device, a
biocompatible plastic should be selected for the loading chamber that is to house the
cartilage tissue and a resilient metal should be selected for the rigid frame of the
apparatus. Additionally, the plastic that is chosen will also be transparent to allow the
user to observe and monitor the experiment in progress.
When constructing the device especially for cartilage tissue applications, the
mechanical stimuli to which the tissue is subjected must be controlled and monitored. In
this regard, certain pumps/motors and sensors must be implemented into the device
construction, and they must be able to withstand the environment of the incubator. They
must be extremely accurate to apply and detect forces that are small enough for the
physiological loading of the tissues or cells. Thus for the construction of the device,
various components must be used to apply small cyclical forces, detect the strain
experienced by the cartilage tissue, and detect the loads placed upon the tissue.
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There are also specific biomechanical requirements that must be considered when
designing a device that will mimic the physiological environment of articular cartilage,
specifically with regard to loading conditions. The device should be able to provide both
static and dynamic compression loading35. Dynamic compression is representative of the
natural environment of cartilage in the joints because the physiological activities of daily
living, such as running/walking, create a cyclical loading environment36. It should be
carefully controlled using a computer and data acquisition system; however, the device
should also be able to do static compression for the purposes of applying a tare load, or
pre-load, to mimic the physiological pressure of cartilage in a joint at rest37.

The

apparatus should provide unconfined compression to the cartilage in the loading chamber
using impermeable platens to act as the subchondral bone of natural cartilage38.
Unconfined compression is defined as axial loading of the samples with free radial
expansion, and it is more representative of the conditions observed in vivo38,39.
The device should be customized to operate in a physiological range of loading
conditions, such as strains, frequencies, and waveforms. Using various methodologies,
such as explant studies and ultrasound imaging, researchers have found that strains in the
range of 0-20% can be considered physiological40-42. The device should also perform
using displacement control as opposed to using load control, because this allows the
samples to be tested from a true “zero”43. Additionally, it has been found that the daily
activities of normal running/walking result in loading frequencies in the joint of
approximately 0.1-2 Hz40. Ideally, the device would also have the ability to emulate
loading conditions that are far above these ranges for further studies on impact loading44.
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Sinusoidal waveforms would be the most useful for characterizing cartilage behavior44,
but additional waveforms, such as saw-tooth and square, would provide the opportunity
for further study. These general and specific requirements must be incorporated into any
mechanical design that is implemented.
There are many different designs that can be used in constructing a dynamic
compression loading device that produces axial motion, but they all must incorporate a
linear actuator of some kind. The most commonly found custom devices in the literature
involve electro-mechanical and electro-magnetic actuators to provide the precision
necessary for cartilage tissue engineering applications. The analysis of these various
designs, as well as a commercially available dynamic compression device, can be seen
below in Table 4.1.
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Table 4.1: Dynamic Compression Loading Devices Commonly Found in Literature
Advantages

Disadvantages




ElectroMechanical
(Threaded
Screw) Actuator
Devices





Simple design
Low cost





ElectroMechanical
(Eccentric Cam)
Actuator Devices







Electro
Magnetic
Actuator Devices 

Commercially
Available
Devices









Simple design
Small, compact
Few small recesses
Low cost



High precision
Smooth with high
regularity
Able to produce many
waveforms of loading
No manufacturing
required
Reliable
Customer support







Moderate precision
Prone to wear
Requires
manufacturing of
custom screw
Screw has many small
recesses
Can’t do high
frequencies with
stepper motor
Requires high
precision feedback
monitoring
Limited to sinusoidal
waveforms of loading
Moderate precision
Prone to wear
Requires
manufacturing of
custom cam
Limited to sinusoidal
waveforms of loading
Complex design
Requires high
precision position
feedback monitoring
High cost
No customization
High cost

Relevant
Literature

Frank et al.;
Hunter et al.;
Lee et al.;
Parkkinen et al.45-48

Cassino et al.;
Mauck et al.49,50

Lujan et al.;
Krishnan et al.;
Park et al.40,51,52
Flexcell®
Compression
Systems
Bose ElectroForce®
System

One of the most popular and easiest implemented designs is that of the electromechanical actuator device, specifically with regard to a threaded screw construction. It
utilizes the principle that with each turn of the actuator’s nut, the shaft of the screw
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moves vertically to produce linear motion from rotary motion. The relevant literature
accomplished devices based on this principle using a lead screw45,46 or a ball screw (lead
screw with ball bearings) that were rotated with a stepper motor. A stepper motor is an
electric motor that can be controlled digitally for precise positioning in axial loading
applications requiring very small magnitudes. This design is simple, carries a relatively
low cost compared to others, and offers a moderate degree of precision.

However to

achieve the precision necessary for cartilage tissue compression, the screw should be
custom-manufactured, and it also requires high precision monitoring components to get
feedback on the screws location during loading. This will add significantly to the cost if
precise experiments are to be conducted. Additionally, this design is limited to lower
frequencies and sinusoidal waveforms, which may be of interest in future studies.
Another type of device found in the literature involved the use of an electromechanical actuator known as an eccentric cam. An eccentric cam is a disc that has a
rotational point that is geometrically off-centered. It is attached to a rotating shaft
powered a motor (a stepper motor in this case), and asymmetrical motion is produced as
the cam itself turns. A piece known as a follower is placed in contact with the eccentric
cam, so that with each rotation of the cam, linear motion is produced. This design is also
simple, carries a relatively low cost compared to others, and offers a moderate degree of
precision. It is also small and compact without the many recesses found in the threaded
screw design that are possible sources of microbial contamination.

The only

disadvantages to this type of device are its moving parts, which are a source of wear, and
the custom manufacturing required for the eccentric cam.
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Some of the more complex dynamic compression loading devices involved the
implementation of a electro-magnetic actuator, such as a voice-coil40,52. A voice coil uses
a current passed through it to produce a magnetic field in which the coil itself moves
through, resulting in linear motion. It is typically seen in audio speakers, but can be
modified for use in precise motion control applications. This design has a higher degree
of precision, due to the need for extremely accurate monitoring components for position
feedback, and it offers smoother movement with a high degree of regularity. However in
light of these facts, it is a much more complex design that carries with it a high cost of
production.
There are also commercially available compression devices on the market, such as
the Flexcell® FX-5000™ Compression and Bose ElectroForce® Sytems. It utilizes a
pneumatic actuator to produce axial dynamic compression on tissue samples or cells.
The advantages to using this piece of equipment, or others like it, are its reliability and
customer support that come with it as well as the fact that no custom manufacturing is
required to perform the compression experiments of interest. However, this device is
extremely expensive and offers no customization if the user desires to expand the range
of experimental conditions.
According to the requirements and literature discussed previously, a design
utilizing the eccentric cam principle of linear motion should be selected due to its low
cost and ease of manufacturing. It has the simplest design with a degree of precision
necessary to replicate the mechanical loading environment of cartilage tissue in the joint.
However, the design should leave room for scale-up opportunities in the future to allow
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for the expansion of its capabilities. The preliminary designs can be seen below in Figure
4.1, and involve the use of a stepper motor, linear variable displacement transducer
(LVDT), and load cell.

These components and the construction of the device are

discussed further in the next section.

Figure 4.1: Sketches of Customized Dynamic Compression Loading Device
Paper and pencil sketch (left); SolidWorks 3D sketch (right)

4.2 Materials and Methods
The support structure of the device was constructed using two 316L stainless-steel
plates screwed together into an L-shape rigid frame. The bottom plate measured 12.70
cm by 15.24 cm with a thickness of 1.27 cm. The vertical plate measured 22.86 cm by
15.2 cm with a thickness of 1.27. A bipolar NEMA23 stepper motor (STP-MTR-23055,
Automation Direct, Cumming, GA) was mounted to the back of the vertical plate and was
attached to an industrial positive drive belt (90XL025, Good Year, Akron, OH). The belt
was then attached to a 316L stainless-steel cam shaft with a length of 8.89 cm that went
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through the vertical plate via a hole that was machined into the plate. A standard
stainless-steel ball bearing cage with an outer diameter of 2.86 cm was used in the hole to
reduce the rotational friction of the cam shaft and ensure smooth axial loading of the
device after assembly. Additionally, spacers (4.60 cm by 3.02 cm by 1.27 cm) and a
bearing holder (7.62 cm by 4.60 cm by 1.27 cm) of 316L stainless-steel were mounted to
the front of the vertical plate to allow for the placement of another 2.86 diameter
stainless-steel ball bearing cage on the front end of the cam shaft. An eccentric cam was
placed on the end of the cam shaft to allow for cyclical axial loading of the device. The
eccentric cam was custom manufactured out of 316L stainless-steel using two circular
plates with a diameter of 3.81 cm. The first plate served as the cam holder (thickness of
1.27 cm), and it went onto the cam shaft through a hole in the back of the plate. The
other plate was the cam itself (thickness of 0.95 cm), and it was attached to the cam
holder via two front mounted screws. The cam has two vertical teeth that extended the
length of the plate to allow the cam to slide up and down on the cam holder. This
allowed the operator of the device to manually adjust the range of axial motion.
Just below the eccentric cam was the 316L stainless-steel slide rail mounting
block, which was fixed to the front of the vertical plate, and the 316L stainless-steel
plunger/bearing holder. A small slide rail system was attached to the mounting block and
the plunger/bearing holder was screwed into the slide rail to allow for vertical motion. A
316L stainless-steel spring was placed on the underside of the plunger/bearing holder to
allow it to return to its position at end of each rotation. Following the eccentric cam was
another stainless-steel bearing cage with an outer diameter of 2.23 cm that was screwed
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into the plunger/bearing holder. This bearing and the plunger/bearing holder served as
the cam follower to allow for cyclical vertical motion. A miniature linear variable
differential transformer (LD400-1, Omega, Stamford, CT), or LVDT, was attached to
both the eccentric cam bearing holder and the plunger/bearing holder. It was used as a
transducer to measure linear displacement and to help provide a means of monitoring
strains on the samples. A 316L stainless-steel plunger shaft with a diameter of 1.27 cm
was housed inside a hole on the underside of the plunger/bearing holder and it was held
in place using two thumb screws. These screws were placed on the front and the side of
the plunger/bearing holder to allow the user to manually adjust the amount of pre-load on
the samples in the loading chamber.
The loading chamber for tissue samples was constructed entirely using
polycarbonate and consisted of an indenter or platen, 12-well tray, and petri dish holder.
The indenter was a flat impermeable plate with a 7.62 cm diameter and it had a threaded
hole at its center so that the threaded end of the plunger could be screwed into the
indenter. A standard petri dish lid with a bored hole in the center was first placed onto
the indenter before securing the plunger into it. This indenter served as the platen that
would actually contact the samples and distribute the load evenly across each one. The
petri dish holder was machined with a 10.16 cm outer diameter and an inner indention of
8.73 cm diameter to hold a standard petri dish. A standard shallow petri dish was used as
a loading chamber in the apparatus, and it was placed on top of the petri dish holder. A
12-well tray with a diameter of 8.26 cm was manufactured to be positioned within the
petri dish for sample placement. A miniature through-hole load cell (LC8100-200-10,
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Omegadyne, Sunbury, OH) was attached to the bottom of the petri dish holder and laid
flat against the surface of the base plate to serve as a transducer to measure force on the
samples.
The electronics that act as signal conditioners and controllers for the stepper
motor (STP-DRV-4035, Automation Direct, Cumming, GA), LVDT (INA118P, Burr
Brown, Tucson, AZ), and load cell (DRF-LC-24VDC-20MV-0/10, Omega, Stamford,
CT) were mounted onto an aluminum sheet with the 24V power supply (S8VM10024AD, Omron, Schaumburg, IL). The assembled dynamic compression apparatus
was controlled and monitored using a custom-built graphical program in LabVIEW 2011
that allows for observation of various outputs such as load and strain. A data acquisition
or DAQ card (NI USB-6009, National Instruments, Austin, TX) was used to convert the
analog signals of the stepper motor, LVDT, and load cell into digital values that could be
processed by the computer. Refer to Appendix A for a more detailed look at the device
drawings and LabVIEW code.
To validate that the device was inexpensive, a cost analysis of the components
used to produce the custom-made dynamic compression loading apparatus was
conducted. Additionally as a validation experiment of the working parameters of the
device, 12 cork samples of 1.5 mm thickness were produced using a 5 mm biopsy punch
and placed into the loading chamber as various loading conditions of 0-20% strain at 1
Hz frequency were tested.
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4.3 Results
The customized pieces of the dynamic compression loading apparatus were
manufactured at a local machine shop using 316L stainless-steel for the rigid structural
components of the device and polycarbonate for the loading chamber components. The
pieces were assembled along with the motor and sensory hardware, seen in Figure 4.2
below.
Gear Belt and Assembly
Eccentric Cam

LVDT

Loading Chamber

Stepper Motor
Load Cell

2

Figure 4.2: Views of the Assembled Dynamic Compression Device
Front view (left); rear view (right)
The eccentric cam and cam follower plunger/bearing that act as the linear actuator
can be seen more readily in the expanded view of Figure 4.3. The electronics that
provide the signal inputs and outputs to allow communication between the computer and
the device are clearly labeled in Figure 4.4.
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Petri Dish and Indenter
Spring

Figure 4.3: Expanded View of Linear
Actuator System

Figure 4.4: View of the Electronics for Device Communication
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Table 4.2: Physical Specifications of the Dynamic Compression Device
Frequency
Strain
Waveforms possible
Materials
Dimensions

Specifications
0.1-10 Hz
~0-40%
Sinusoidal only
316L stainless-steel (frame)
Polycarbonate (loading chamber)
26.26 cm (height)
15.24 cm (width)
12.7 cm (depth)

Table 4.3: Cost Analysis of Assembled Dynamic Compression Loading Apparatus
Device Component
Bipolar stepper motor
Stainless-steel ball bearing cages (3)
Gear belt and assembly
Linear Slide Rail
LVDT
Load cell
Stepper motor driver
Load cell signal conditioner
Multi-function DAQ card
24 V power supply
Various electronics
Mounting hardware
Aluminum mounting plate
Bulk material
Bulk material

Component Product
Number
STP-MTR-23055
Standard
90XL025 and standard
Standard
LD400-1
LC8100-200-10
STP-DRV-4035
DRF-LC-24VDC-20MV-0/10
NI USB-6009
S8VM-10024AD
Assorted components
Standard
Standard
316L Stainless-Steel
Polycarbonate
Total

Price
$35.50
$42.14
$105.41
$154.95
$387.37
$497.37
$166.25
$217.37
$251.10
$161.35
~$100.00
~$20.00
~$64.00
~$200.00
~$100.00
~$2500.00

Table 4.2 gives the physical specifications of the assembled device in both its
performance and measurements to indicate whether specific design targets discussed
previously were met. The dynamic compression apparatus is displacement controlled and
as such there are no specifications given for the load. Table 4.3 is a cost analysis of the
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completed device to indicate the expenses incurred as well as to analyze its costeffectiveness.

Loading Per Sample of Cork Samples at Various
Time Points
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Figure 4.5: Load Measurements of Cork Samples

Strain of Cork Samples at Various Time Points
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Figure 4.6: Strain Measurements of Cork Samples
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Cork samples were used for validation of the dynamic compression apparatus and
the graphs for the resulting load per sample and strain outputs at various time points can
be seen in Figures 4.5 and 4.6, respectively. The purpose of these graphs is to show the
reliability and consistency of the device during the course of an experiment. The loading
per sample and strain at each of the various time points is given in Table 4.4 as an
average with the standard deviation.

Using a one-way ANOVA test with a Tukey

method of multiple comparisons, the samples at the 1 minute time point showed loading
that was statistically different (p<0.05) from the other time points. The range of the
loading per sample values at each of the time points recorded were approximately 0.14 to
1.22 N (1 minute), 0.10 to 1.13 N (1 hour), and 0.12 to 1.07 N (2 hours). The range of
the strain values at each of the time points recorded were approximately -4.20 to 18.97%
(1 minute), -2.65 to 15.58% (1 hour), and -2.59 to 16.65% (2 hours).

Table 4.4: Average Load and Strain Values of Cork Samples
Load per sample [N]
Strain [%]

1 Minute
0.64±0.31*
6.46±6.08

1 Hour
0.49±0.27
6.51±5.75

2 Hours
0.50±0.28
6.40±5.75

*Statistically significant difference (p<0.05) compared to other time points

Lastly, the total stress over all 12 samples was calculated, and the strain-stress
behavior of the cork samples was graphed for a single representative cycle at the 1 hour
time point (Figure 4.7). The peak stress appears to be approximately 0.55 MPa and
occurs at approximately 13% strain.
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Strain-Stress Behavior of Cork Samples In
Dynamic Compression
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Figure 4.7: Strain-Stress Behavior of Cork Samples

4.4 Discussion
The assembled device proved to be capable of effectively providing dynamic
axial loading on samples in the polycarbonate chamber. The electronics allowed for the
frequency of loading to be digitally controlled with the aid of a computer, and it also
provided outputs of the loading per sample as well as the strain.

The desired

displacement had to be set manually before experimentation, and the procedure for doing
so can be found at the back of Appendix A. Physically, the device was able to produce
physiological frequencies in the range of 0.1-2 Hz and even as high as 10 Hz, which
would be useful in doing high impact loading in future studies. The apparatus was able
to produce physiological strains in the range of 0-20% and even as high as 40%, which
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will also be useful in doing high impact loading in future studies. Unfortunately the
device, due to its electro-mechanical linear actuator, is only able to produce sinusoidal
waveforms. This is adequate for the current study of articular cartilage biomechanics, but
other waveforms may be required in future studies. The device was constructed of 316L
stainless-steel, which resists the harsh conditions of the incubator, and polycarbonate,
which acts as a biocompatible loading chamber for biological samples. The assembled
product also has dimensions that allow for it to fit easily into a standard incubator.
Lastly, the device was shown to have a relatively low cost in comparison to other types
found in the literature.
The validation tests with the cork samples were able to prove that the device
performs reliably with consistent outputs of load and strain data over the course of an
experimental trial. The average loading per sample for the first time point was found to
have a statistically significant difference (p<0.05) compared to the other time points, and
this could be due to the device needing an equilibration period that is longer than one
minute. The strain values that were observed in this validation test indicate that the range
is relatively close to the 0-20% strain that was set, but negative strains were observed in
the range. This does not mean that lift-off of the samples is occurring; instead, it
indicates that the device was improperly zeroed before experimentation began. This is
important for obtaining accurate data and must be considered more closely for the
remainder of this study. The strain-stress behavior of the cork samples was graphed for a
single representative cycle at the 1 hour time point because it was at this point that it
seemed the device had reached an appropriate equilibrium to obtain accurate
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measurements. The profile and plateau stress that was observed in the graph matches
what is found in the literature for the strain-stress behavior of agglomerate cork
behavior53.
4.5 Conclusion
The custom-designed dynamic compression apparatus that has been constructed
and assembled fulfills the desired requirements to be simple, low-cost, durable, and
capable of providing axial loading within established parameters. It has proven to be an
accurate and reliable device that can effectively be used to provide physiological loading
conditions in the study of articular cartilage tissue biomechanics. The device will be used
further in the next chapter to provide dynamic compression to cartilage tissue explants to
observe gold nanoparticle permeation.

In the future, the device could incorporate

hydrostatic flow into the loading chamber to ensure a constant concentration of the
nanoparticles of interest in media. Additionally, the device could incorporate a ball and
socket pivot joint at the intersection of the indenter and plunger. This would allow for
easier removal of the loading chamber as well as for making sure that the indenter can
contact all of the samples effectively. To integrate shear forces into the design and thus
make it even more physiological, the loading chamber could be made to rotate using the
stepper motor.
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CHAPTER 5: GOLD NANOPARTICLE PERMEATION IN RESPONSE TO
DYNAMIC COMPRESSION OF ARTICULAR CARTILAGE

In order to determine the potential for using gold nanoparticles as a drug delivery
system in articular cartilage repair, the permeability as well as the convective transport of
the nanoparticles in physiologically loaded tissue must be observed. The following
chapter details the experiments that were conducted to characterize the permeation of
gold nanoparticles into articular cartilage under various loading conditions.

5.1 Background
The primary function of cartilage found in the joints is to provide a smooth,
articulating surface between bones as well as to act as a shock absorber in distributing
loads. The tissue is flexible and resilient with a low coefficient of friction to perform
these tasks effectively. The main components that make up the dry-weight of articular
cartilage are collagen fibers and large macromolecules called proteoglycans.

The

collagen fibers function to resist tensile forces experienced by the joint, while the
proteoglycans function to resist compressive forces experienced by the joint.

In

particular, the mechanical loading that is of utmost importance to the study of the
biomechanics of physiological articular cartilage is that of unconfined axial
compression39. The reason that cartilage is so effective in dispersing compressive loads
is due to the unique physical properties that are offered by the chemistry of the
proteoglycan in the extracellular matrix. The proteoglycans have glycosaminoglycan
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(GAG) chains made up of chondroitin sulfate, keratin sulfate, and hyaluronan. These
chains have an overall net negative charge that lends a high degree of hydrophilicity to
the proteoglycan macromolecules. Thus, articular cartilage contains consists of 60-80%
water that is pressurized during compression and supports the majority of the load.
Changes to the biochemical composition of the extracellular matrix due to high
impact injury or aging can cause a reduction in the water content of cartilage. This
results in cartilage pathology as there is decreased fluid pressurization and higher loading
on the tissue itself. Over time the tissue will experience degradation, and this is readily
seen in osteoarthritis with widespread structural damage of grades II and III. It is the
most common joint disorder affecting over half of the adult population, and it is on the
rise. Unfortunately articular cartilage has an extremely limited capacity for self-renewal.
This inability to repair is primarily due to the avascular nature of cartilage, meaning all of
the nutrients must come from the surrounding synovial fluid via diffusion.

Articular

cartilage exhibits permeability properties that favor the passive diffusion of small
molecules, and it is mediated by the physiological motion in the joint. This property
could possibly be used advantageously in drug delivery systems of small molecules.
Nanotechnology is a field that is garnering a lot of attention lately for its potential
for use in a multitude of biomedical applications. Specifically, gold nanoparticles have
many properties that make them ideal candidates in smart drug delivery systems. They
can be manufactured to many different sizes and shapes depending on the application.
Gold nanoparticles are biocompatible and can undergo surface modification to target
specific biological sites of interest, thereby making them more precise in delivery
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compared to traditional means of drug administration. They are on the same scale as the
cellular species of interest, and due to their small size, the nanoparticles are not quickly
removed from the body allowing prolonged drug delivery times. They can also be easily
characterized using electron microscopy due their high electron density. Various drugs,
growth factors, or genes could be conjugated on gold nanoparticles to make them
effective in treating articular cartilage damage. This is an area of research with great
potential, but the loading conditions that optimize permeation of gold nanoparticles into
articular cartilage must first be studied.
5.2 Materials and Methods
Articular cartilage explants were harvested from the tibio-femoral joints of freshly
slaughtered porcine juveniles (less than 1-year-old) obtained from a local abattoir. The
joint was exposed, and the articular surface of the femoral condyle was sliced in
horizontal sections. A 5 mm biopsy punch was then used on the flat slices to obtain
cartilage plugs with an approximate thickness of 1.5 mm. If the samples were measured
to be too thick, the surface of the underlying subchondral bone could be removed with the
aid of a scalpel to achieve the correct thickness. This is to ensure the samples are roughly
the same thickness for uniform loading during experimentation35. After removal, the
plugs were placed in sterile Hank’s Balanced Salt Solution (HBSS) that has been
supplemented with 1% antibiotic/antimycotic solution (penicillin/streptomycin) and 1%
antifungal solution (amphotericin B) to stabilize the tissue until loading.
Using sterile technique, up to 12 samples were then evenly placed with 10 mL of
growth media into the petri dish loading chamber of the custom dynamic compression
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loading apparatus discussed in the previous chapter, as shown in Figure 5.1. For the
experiments, a cartilage culture growth media was used, and it contained low-glucose
Dulbecco’s Modiﬁed Essential Medium (DMEM) with 10 mM HEPES, 0.4 mM proline,
0.02 mg/mL ascorbic acid, 10% fetal bovine serum (FBS), 1% nonessential amino acids,
1% antibiotic/antimycotic solution (penicillin/streptomycin), and 1% antifungal solution
(Amphotericin B).

For each experiment with gold nanoparticles, 2 mL of gold

nanoparticle solution was also added to the 10 mL of growth media to yield a final gold
nanoparticle concentration of ~1.08E11 particles/mL. The gold nanoparticles used for
this study had an average particle diameter of 20 nm and were suspended in 0.1 mM
reactant-free PBS at a concentration of ~6.5E11 particles/mL (753610, Sigma Aldrich,
St. Louis, MO).

Figure 5.1: Explant Placement in
Loading Chamber
The loading chamber with the samples was then placed into the dynamic
compression device, and a static load was applied for one hour. This allowed the

52

cartilage explants to equilibrate and ensured there was no creep behavior during
experimentation. After the allotted one hour, the strain and load were zeroed so that a
nonzero pre-load could be established for the samples. This offset load was set to make
certain that the indenter maintained contact during the entire loading period with no liftoff. Then the loading parameters were set for each experiment (static compression at a
strain of 7.5%, dynamic physiological compression of 0.1 Hz at a strain of 0-15%, and
dynamic physiological compression of 1.0 Hz at a strain of 0-15%), and it was allowed to
run for two hours. Additionally, free-swelling cartilage explants were used as a control,
and these samples were placed alongside the device in a standard petri dish with 10 mL
of cartilage media and 2 mL of gold nanoparticles for the same time period.
Measurements of the load and strain were taken after one hour of dynamic loading.
The following procedures were carried out in each experiment:
After loading, one explant and 1 mL of the cartilage media were set aside for
biochemical analysis using a DMMB assay. The sample that was set aside was digested
in a solution containing 10 mg of Pronase E (P8811, Sigma Aldrich, St. Louis, MO) and
1 mL of distilled water. It was incubated and shaken overnight at 56°C in an incubated
orbital shaker until the cartilage was completely digested with no visible residue. The
digested cartilage explant and the media were then analyzed for proteoglycan content
using a DMMB assay (see Appendix B for the protocol).
The other samples were divided into two groups with half of the samples fixed in
10% neutral buffered formalin for histological analysis, and the other half fixed in 2.75%
gluteraldehyde (see Appendix D for details on formulation) for electron microscopy
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analysis. After at least two days of fixation, the formalin fixed samples were assigned a
specimen number and processed using standard tissue processing procedure (using ethyl
alcohol in increasing concentration, xylene as a clearing agent, paraffin as an infiltrating
agent, and paraffin as an embedding agent). The samples were then sectioned using an
automatic microtome yielding 5μm thick sections that were placed on microscope slides.
After drying overnight in an oven, the sections were stained using a hematoxylin & eosin
(H&E) and a special safranin O green protocol (see Appendix C). After staining the
slides were coverslipped and imaged on a Nikon Labophot 2 standard light microscope
with attached Sony HDR-HC9 high definition camcorder. The histological analysis was
done to observe if the various loading parameters caused any pathology in the tissue.
After at least two days of fixation, the gluteraldehyde fixed samples were
assigned a specimen number and prepared for electron microscopy analysis using a series
of increasing ethanol washes. The SEM prepared samples were additionally immersed in
HMDS, while the TEM samples were polymerized overnight in pure resin and sectioned
using an ultramicrotome. The SEM samples were then analyzed using a Hitachi SU6600
Schottky Field Emission Analytical SEM microscope and a Hitachi HD2000 STEM
microscope. This was done to observe gold nanoparticles on the surface of the articular
cartilage and to conduct an elemental analysis with energy-dispersive X-ray spectroscopy
(EDX). EDX focuses a high-energy beam at the sample and measures the energy of the
X-rays that are emitted back as a result, which are unique depending upon the chemical
composition of the location of interest on the sample. The TEM samples were then
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analyzed using a Hitachi H7600 TEM microscope. This was done to observe gold
nanoparticles that had penetrated into the articular cartilage.
5.3 Results
Articular cartilage samples were tested under various loading parameters to
observe the effects of loading on gold nanoparticle permeation into the tissue, and the
resulting load per sample and strain outputs for each set of conditions was graphed in
Figures 5.2 and 5.3, respectively. The purpose of these graphs is to show the specific
loading conditions of each experiment.
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Figure 5.2: Load Measurements of Articular Cartilage Explants
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Figure 5.3: Strain Measurements of Articular Cartilage Explants

The loading per sample and strain in each experiment is given in Table 5.1 as an
average with the standard deviation. The range of the loading per sample values in each
of the experiments were approximately 0.56 to 0.60 N (Static), 0.19 to 1.58 N (0.1 Hz),
and 0.14 to 1.45 N (1.0 Hz). The range of the strain values in each of the experiments
were approximately 6.87 to 8.08% (Static), 0 to 16.89% (0.1 Hz), and 0 to 15.49% (1.0
Hz).

Table 5.1: Average Load and Strain Values of Articular Cartilage Explants
Load per sample [N]
Strain [%]

Static
0.58±0.01
7.55±0.20

0.1 Hz
0.78±0.45
9.02±5.27
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1.0 Hz
0.68±0.41
7.42±4.96

The DMMB assay was run on the digested cartilage and cartilage media for each
experiment, and the values were compared to a standard curve (Appendix B) to obtain
proteoglycan concentrations for each solution. The resulting concentrations are shown in
Figure 5.4 for the digested cartilage solution and Figure 5.5 for the cartilage media.
Using a one-way ANOVA test with a Tukey method of multiple comparisons, no
significant differences were found for the digested cartilage solutions.

However, a

significant difference (p<0.05) was found for the cartilage media in which the explants
had been loaded with static compression.

DMMB Assay on Digested Cartilage Solution
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Figure 5.4: Proteoglycan Concentration in Digested Cartilage Solutions
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DMMB Assay on Cartilage Media
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Loading
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No Loading

Figure 5.5: Proteoglycan Concentration in Cartilage Media
*Statistically significant difference (p<0.05) compared other samples

The histological images for each of the experiments after loading can be seen in
the representative images of Figure 5.6. All images were taken with a 10x objective
(100x total magnification). In the H&E stain, the nuclei of the chondrocytes stain blue
and the cytoplasm and other tissue elements stain various shades of pink. In the Saf O
Green stain, the nuclei stain purple/black, muccopolysaccharides stain orange red, and
collagen fibers stain green.
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Saf O Green

1.0 Hz
Dynamic Compression

0.1 Hz
Dynamic Compression

Static Compression

Free Swelling Control

H&E

Figure 5.6: Histological Analysis of Articular Cartilage after Loading
Labeled on top and left side of the figure
10x objective (100x total magnification); all scale bars are 100 μm
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For each of the experiments after loading, representative images of the articular
cartilage using scanning electron microscopy can be seen in Figure 5.7, and they were
taken with the SU6600 SEM at 15k magnification and 60k magnification under variable
pressure (VP) mode using a 20kV voltage. Additionally using SEM, the image in Figure
5.8 was taken with the HD2000 STEM at 450k magnification under VP mode using
200kV.

This image shows a higher magnification (450k magnification) of a gold

nanoparticle found in a 1.0 Hz dynamically compressed tissue sample, and it was
measured to be approximately 23.24 nm in diameter. Using the SU6600, EDX reports
for the 0.1 Hz and 1.0 Hz dynamically compressed cartilage samples can be seen in the
representative images of Figures 5.9 and 5.10, respectively. The EDX results indicate a
0.25±0.10 weight percent of gold in the 0.1 Hz dynamically compressed samples and a
0.47±0.19 weight percent of gold in the 1.0 Hz dynamically compressed samples. The
EDX reports of the free-swelling control and the statically compressed samples were not
included due to its inability to detect any gold for these samples. All of the EDX results
were compiled and summarized graphically, as shown in Figure 5.11. It should be noted
that only EDX reports showing gold with a detected weight percent at least two standard
deviations above the sigma value were used.
For the 0.1 Hz dynamically compressed samples and the 1.0 Hz dynamically
compressed samples, representative images of the articular cartilage using transmission
electron microscopy can be seen in Figures 5.13 and 5.14, respectively. They were taken
with the H7600 at 60k magnification under VP mode using a 120kV voltage.
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SEM at 60k Magnification

1.0 Hz
Dynamic Compression

0.1 Hz
Dynamic Compression

Static Compression

Free Swelling Control

SEM at 15k Magnification

Figure 5.7: SEM Analysis of Articular Cartilage after Loading
Labeled on top and left side of the figure
Scale bars are 3 μm for the images on the left and 500 nm for the images on the right
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23.24 nm

Figure 5.8: Higher Magnification Image of Gold Nanoparticle

Figure 5.9: EDX Report for Samples in 0.1 Hz Dynamic Compression Loading
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Figure 5.10: EDX Report for the Samples in 1.0 Hz Dynamic Compression Loading
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Figure 5.11: EDX Detection of Gold in Samples
* Statistically significant difference (p<0.05) compared other samples
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No loading

Figure 5.12: TEM Analysis of 0.1 Hz Dynamic Compression Sample

Figure 5.13: TEM Analysis of 1.0 Hz Dynamic Compression Sample
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5.4 Discussion
The explant samples were tested under various loading conditions that were
shown to be set accurately in the physiological range of articular cartilage using the
custom dynamic compression loading apparatus discussed in the previous chapter. For
biochemical analysis after loading, a DMMB assay was conducted to measure the
concentration of proteoglycans. It was found that there was no difference between the
amounts of proteoglycan in the digested explant for each experiment, and this could be
due to short time frame under which the samples were tested. In future studies, the
explants could be tested for a longer time frame to observe the effects of various loading
conditions on the stimulation of proteoglycans. However, the concentrations that were
found were outside of the range that the assay can detect using the standard curve found
in Appendix B (0.01-0.05 μg/mL). Adjustments to the protocol could be made in future
experiments to obtain more reliable results on the proteoglycan concentration of the
explants. Additionally, it was found that there was a statistically significant difference
between the amounts of proteoglycan in the cartilage media under static loading
compared to the other samples. This could be due to potential damage to the explants
that is caused by the non-ideal conditions of static loading, as it has been shown in the
literature to inhibit proteoglycan synthesis in articular cartilage32,33.
The histological analysis of the cartilage after loading indicates that no damage to
the tissue can be readily observed. The staining and morphology are characteristic of
normal, healthy articular cartilage. Thus, the loading conditions in each experiment
appear to have no adverse effects on the samples.
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After histological analysis, each of the samples was imaged using scanning
electron microscopy to observe the amount of gold nanoparticles on the surface of the
tissue due to the various loading conditions. In the SEM images that were obtained with
the SU6600, no nanoparticles could be observed in the free swelling control or the
statically compressed samples. However, the samples in dynamic compression indicate
the presence of nanoparticles that were roughly spherical in shape and had a high electron
density due to their bright white appearance. The nanoparticles were found to be much
more prevalent in the samples after 1.0 Hz dynamic compression. However, it could not
be concluded solely from these images that the nanoparticles were the gold nanoparticles
of interest. Thus, a higher magnification image of a particle was required to determine
size/shape and EDX was required to confirm the presence of gold.
The gold nanoparticles used for experimentation were 20 nm diameter spheres,
and this is consistent with the findings of the higher magnification image indicating that
the imaged particle was of a definite spherical shape with a diameter of 23.24 nm. The
EDX reports for the 0.1 Hz and 1.0 Hz dynamically compressed samples indicate the
presence of gold in very small quantities, along with other elements known to be present
in articular cartilage. The EDX results that were graphically summarized indicate that
there is a significantly significant difference (p<0.05) in the amount of gold detected in
the samples. It appears that the samples in 1.0 Hz dynamic compression loading have a
higher presence of gold compared to the samples in 0.1 Hz dynamic compression
loading. The EDX results for the free-swelling control explants and the explants in static
loading indicated that there is no gold to be found in these samples.
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Lastly, the samples in 0.1 Hz dynamic compression and 1.0 Hz dynamic
compression were imaged using transmission electron microscopy to observe the amount
of gold nanoparticle permeation into the tissue due to the various loading conditions. In
the TEM images that were obtained with the H7600, nanoparticles with a high electron
density were observed due to the appearance of black spots in the sample that weren’t
artifacts. The nanoparticles were found to be much more prevalent in the samples after
1.0 Hz dynamic compression.

It cannot be concluded from these images that the

nanoparticles were the gold nanoparticles of interest, and EDX is ineffective at analyzing
the chemical composition of a singular nanoparticle.
5.5 Conclusion
The dynamic compression device that was constructed in the previous chapter
was effective at providing physiological loading to articular cartilage explants. Under the
various loading conditions that were tested, relatively no adverse effects were observed
on the tissue. From the SEM and EDX results, there seems to be sufficient evidence to
conclude that the particles observed on the surface of the dynamically compressed
samples is in fact the gold nanoparticles of interest.

From the TEM results, small

nanoparticles that may potentially be gold were observed within the explants.
Qualitatively, more gold nanoparticles were observed in the 1.0 dynamically compressed
samples both on the surface and inside of the articular cartilage tissue as compared to the
other samples.
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CHAPTER 6: OVERALL CONCLUSIONS AND FUTURE WORK

Research has been ongoing in the search for a cure for articular cartilage damage,
especially in the case of osteoarthritis. With an aging population and the prevalence of
obesity, the need for a suitable treatment is growing. Gold nanoparticles offer abundant
potential as a smart drug delivery mechanism in bringing growth factors, drugs, or genes
to diseased cartilage tissue in the joints. However, not enough is known about the
biomechanical aspect of gold nanoparticle permeation into this tissue. This research
focused on determining the extent of gold nanoparticle permeation and the physiological
loading conditions that optimize its convective transport.
This work was able to find a means of providing loading conditions necessary in
the study of articular cartilage through the design and construction of a custom dynamic
compression apparatus. It was also shown that under compressive loading of articular
cartilage, gold nanoparticles were observed on the surface and potentially inside the
tissue. Gold nanoparticles were shown to permeate into the tissue with the addition of
convective transport caused by higher frequency physiological motion. This has clinical
significance for determining an optimal loading regiment for delivering drugs in patients
that may undergo gold nanoparticle treatment. Osteoarthritis has been shown to result in
an increased permeability in the articular cartilage55, and therefore it is expected that
there will be an increased amount of gold nanoparticle permeation into diseased tissue.
However, more experiments should be conducted on osteoarthritic tissue to obtain more
accurate data on the permeation of gold nanoparticles.
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To continue this research, the amount of permeation of gold nanoparticles should
be established quantitatively through the use of fluorescently-labeled gold nanoparticles
that can be observed using standard fluorescent imaging as opposed to electron
microscopy. In this way, the amount of gold nanoparticle permeation in specific zones of
the articular cartilage could be observed to draw more conclusions. Additionally more
research should be conducted on the permeation into the tissue over time to better
characterize the diffusive phenomena that are occurring.
In the current work, gold nanoparticle permeation was observed, but using the
dynamic compression loading apparatus, a multitude of unrelated experiments could be
performed. High impact loading studies or even studies on the loading of other tissues,
such as dental pulp stem cells, could be conducted in the future.
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APPENDIX A: ADDITIONAL DRAWINGS, COMPUTER CODE, AND
PROCEDURES OF THE DYNAMIC COMPRESSION LOADING APPARATUS

Figure A.1: Detailed CAD Drawing of the Vertical Plate

Figure A.2: Detailed CAD Drawing of the Bottom Plate
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Figure A.3: Detailed CAD Drawing of the Cam Assembly

Figure A.4: Detailed CAD Drawing of the Plunger Assembly
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Figure A.5: Detailed CAD Drawing of the Loading Chamber Assembly
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Figure A.6: LabVIEW Block Diagram of Computer Control Code
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Procedure for Operation of the Dynamic Compression Loading Apparatus
1. Ensure all connections are secure (Power, USB, Load Cell, LVDT, Stepper
Motor) and turn the device ON
2. Open LabVIEW and run the program associated with the device
a. Open LabVIEW 2011
b. Open the existing Dynamic Loading System project
c. Open the MainVI within the project
3. Set sample thickness (0.5-2 mm) and number of samples (1-12 samples)
4. After loading samples, insert the loading chamber
a. Lift the plunger
b. Insert loading chamber containing samples (ensuring sterile technique if
necessary)
c. Screw down plunger into the threaded hole of the indenter (may be helpful
to lift the plunger slightly while screwing it down) and tighten the thumb
screws (to ensure no movement during transfer to incubator)
d. Place in incubator (running cords through back) and loosen plunger once
placed
5. Run the VI
6. Rotate the cam to align the screw holes horizontally and click the Zero LVDT
button
7. Set the strain
a. Rotate the cam to align the screw holes vertically
b. Loosen the eccentric cam using a 7/64” Allen wrench
c. Adjust the cam by pushing down or letting up with your finger until you
achieved a strain that is half of the total desired strain (i.e. set 10% for
total desired strain 20%)
d. Tighten the cam using the Allen wrench
e. Ensure that the strain is still at the correct value (sometimes it moves
slightly when you tighten the cam so you may have to set it higher before
tightening to compensate)
8. Zero the LVDT
a. Rotate the cam until the strain value is at zero (at the cam’s highest point)
b. Click the Zero LVDT button
9. Zero the Load Cell
a. Slightly lift the platen off the samples (ensure sterility if necessary)
b. Click the Zero Load Cell button
c. Release, apply a little more load with your fingers, and tighten the platen
(the non-zero value that is shown on the Force graph indicates the Preload and this ensures that lift off does not occur during the loading cycle)
10. Set motor speed
a. Set the motor speed at the frequency you wish to run samples (0.1-10 Hz)
b. Click the green button to begin dynamic compression
11. Use the export images button at various time points to record the data
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APPENDIX B: BIOCHEMICAL ANALYSIS OF ARTICULAR CARTILAGE
DMMB Assay of Cartilage Media/Digested Cartilage
Written by: Alex Lindburg-MBEM Lab
Materials
1. Chondroitin sulfate (Sigma C4384)
2. 1,9-dimethylmethylene blue reagent (Sigma 341088) [See Notes 1 & 2]
3. Glycine
4. NaCl
5. HCl
6. 96-well plates [with U-shaped bottoms]
Directions
1. 20 L aliquots of media in triplicate should be used for analysis.
2. The sample with the GAG highest concentration should be tested so an
appropriate dilution can be made [See Note 3].
3. A standard curve should be made for comparison of media to solutions of known
chondroitin sulfate concentrations. The following dilutions should be made: 0.05,
0.04, 0.03, 0.02, 0.01, 0.005, and 0 g/L. Make a working solution of 0.05
g/L by adding 2.0 mg of CS powder to 40 mL of media.
Working Solution (L)
100
80
60
40
20
10
0

Media (L)
0
20
40
60
80
90
100

Final Concentration (g/L)
0.05
0.04
0.03
0.02
0.01
0.005
0

4. 180 L of DMMB is added to each well using a multi-channel pipet
5. The absorbance at 530 nm is measured immediately with a microtiter plate reader.
Notes
1. The working solution is made by dissolving 16 mg of DMMB dye in 1 L of water
containing 3.04 g glycine , 2.37 g NaCl, and 95 mL of 0.1 M HCl.
2. The solution should be stored at room temperature in a brown bottle. The solution
is stable for up to 2 months.
3. The linear concentration of chondroitin sulfate in DMMB is limited to between 10
and 50 g/mL (0.2 and 1.0 g in 20 L of solution).
Reference
Mort, JS and PJ Roughley. Measurement of glycosaminoglycan release from cartilage
explants. (2007) Methods in Molecular Medicine. 135, 201-209.
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Absorbance

DMMB Assay Standard Curve
0.20
0.18
0.16
0.14
0.12
0.10
0.08
0.06
0.04
0.02
0.00

y = 3.4914x + 0.0056
R² = 0.9828

0

0.01

0.02

0.03

Concentration [µg/mL]

Figure B.1: Standard Curve Used in DMMB Assay Results
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APPENDIX C: HISTOLOGY PROTOCOLS
Richard AllanTM
Hematoxylin & Eosin Stain
Written by: Linda Jenkins
Fixation: Any
Technique: Paraffin or frozen
Solutions:
Hematoxylin I
Richard- Allan-----------------------Order # 7221
Clarifier I
Richard- Allan-----------------------Order # 7401
Bluing Reagent
Richard- Allan-----------------------Order # 7301
Eosin-Y
Richard- Allan-----------------------Order # 7111
*Add “dash” of Phloxine B, C.I. #45410 to one pint of Eosin-Y and mix thoroughly
Staining Procedure:
1. Xylene
10 dips
2. Xylene
5 minutes
3. 100% EtOH
10 dips
4. 100% EtOH
1 minute
5. 95% EtOH
10 dips
6. 95% EtOH
1 minute
7. Tap water
30 seconds
8. Distilled water
1 minute
9. Hematoxylin
5 minutes
10. Tap water
30 seconds
11. Clarifier
30 seconds
12. Bluing reagent
1 minute
13. Tap water
1 minute
14. 95% EtOH
10 quick dips
15. Eosin
45 seconds
16. 95% EtOH
10 quick dips
17. 95% EtOH
10 quick dips
18. 100% EtOH
10 dips
19. 100% EtOH
1 minute
20. 100% EtOH
3 minutes
21. Xylene
10 dips
22. Xylene
5 minutes
Let slides remain in last container of xylene until a coverslip is applied
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Special Staining Procedure
Safranin O Green
Written by: Linda Jenkins
Fixation: 10% Neutral Buffered Formalin
Technique: Paraffin
Solutions:
0.2% Fast Green
0.1% Safranin O
1% Glacial Acetic Acid
Weigerts Hematoxylin A & B
Staining Procedure:
1. Xylene
10 dips
2. Xylene
5 minutes
3. 100% EtOH
10 dips
4. 100% EtOH
1 minute
5. 95% EtOH
10 dips
6. 95% EtOH
1 minute
7. Tap water
30 seconds
8. Distilled water
1 minute
9. Weigerts Hematoxylin
10 minutes
10. Tap water
30 seconds
11. Fast Green
5 minutes
12. Acetic acid
3 dips
13. Safranin O
6 minutes
14. 95% EtOH
2 ½ minutes
15. 95% EtOH
2 ½ minutes
16. 100% EtOH
2 ½ minutes
17. 100% EtOH
2 ½ minutes
*The final 100% alcohol must be absolutely clear to remove excess Safranin O
18. Xylene
5 minutes
19. Xylene
5 minutes
Let slides remain in last container of xylene until a coverslip is applied
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APPENDIX D: ELECTRON MICROSCOPY PREPARATION PROTOCOLS
Gluteraldehyde Fixative and Rinsing Buffer Solution Preparation
Written by: Clemson University Electron Microscope Facility Staff
Preparation of Solution for 0.2 M Cacodylate Buffer
1. 0.4 M sodium cacodylate
50 mL
2. 0.2 M HCl
8 mL
3. Distilled water to make
100 mL
*The pH of the solution is adjusted to the required value with the HCl
Preparation of Solution for 2.75% Gluteraldehyde:
1. 0.2 M cacodylate buffer
50 mL
2. 25% gluteraldehyde
10 mL
3. Distilled water to make
100 mL
*The pH of the solution is adjusted to the required value (typically 7.0) with HCl or
NaOH and should be discarded if it drops below 3.5
**Store in a dark bottle in the refrigerator. It is stable for several weeks.
Preparation of Solution for Rinsing Buffer
1. Cacodylate
21.0 g
2. Sucrose
73 g
3. Distilled water
800 mL
*The pH of the solution is adjusted to the required value (7.2-7.4) with HCl or NaOH
**Bring to 1000 mL with distilled water
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Procedure for TEM Preparation
Written by: Clemson University Electron Microscope Facility Staff
1. Rinse in rinsing buffer
2. Dehydrate in EtOH
a. 50% EtOH
15 minutes
b. 70% EtOH
15 minutes
c. 80% EtOH
15 minutes
d. 95% EtOH
15 minutes
e. 100% EtOH
30 minutes
f. 100% EtOH
30 minutes
g. 100% EtOH with embedding media (LR White) until samples sink to the
bottom of the container
h. Embedding media until samples sink to the bottom of the container (can
put on a rocker plate to increase infiltration or refrigerate overnight)
3. Embed into pure resin
4. Polymerize at 60°C in an oven overnight
5. Microtome using ultramicrotome and mount sections on TEM grids

Procedure for SEM Preparation
Written by: Clemson University Electron Microscope Facility Staff
1. Dehydrate in EtOH
a. 70% EtOH
10 minutes
b. 85% EtOH
10 minutes
c. 95% EtOH
10 minutes
d. 100% EtOH
10 minutes
2. Immerse tissues in HMDS for 15 minutes.
3. Leave the HMDS in the containers and let it evaporate overnight at room
temperature in a fume hood.
4. Mount tissues on stainless-steel SEM stubs
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